Psoriasis is a chronic non-infectious disease of a multifactorial nature, which often occurs in the form of rashes and peeling of the skin. Psoriasis occupies a significant share in the dermatological structure of diseases at the present time. [1, 2]. Despite the numerous scientific studies conducted by scientists in many countries regarding the etiology, pathogenesis, clinic and treatment of psoriasis, there is still a question about the main cause of the disease.In a significant number of patients with psoriasis, lesions of the nervous system, cardiovascular, gastrointestinal pathology, pathology of the genitourinary system, as well as, often with damage to the articular systems of the skeleton together with disorders of the immune system, were revealed. All this indicates the multifactorial nature of the disease. In this regard, the search for optimal drugs that would affect several pathogenetic links of the disease is currently underway. [3, 4,]. Therefore, today, we consider this issue relevant.
